GH1 and acromegaly: The persistence of plasma GH achieved in these studies is markedly different from the pathological states of elevated GH exposure, where Igf1 production shows major dysregulation in both GH resistance (IGF1 suppression) and acromegaly (IGF1 induction) (67).